Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.

K Eberhardt, E Fex
{"title":"Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.","authors":"K Eberhardt,&nbsp;E Fex","doi":"10.1093/rheumatology/37.12.1324","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical course in early rheumatoid arthritis (RA) patients followed prospectively, to relate course to outcome after 5 yr, and to try to identify prognostic features.</p><p><strong>Methods: </strong>A total of 183 patients with definite RA and a mean disease duration of 11 months were included. Of these, 75% were rheumatoid factor (RF) positive; 85% carried the shared epitope, 32% on both alleles. Most patients were assessed every 6 months. Disability was evaluated with the Health Assessment Questionnaire (HAQ) and radiographic findings according to Larsen. Remission was defined in two ways: with the American Rheumatism Association (ARA) criteria and as 'no arthritis at least at one follow-up visit'.</p><p><strong>Results: </strong>Twenty per cent achieved ARA-defined remission periods of at least 6 months duration; 21 were spontaneous and 18 drug induced. Average length of remission was 20.5 months. The remission periods constituted 7% of follow-up for all patients. Another 36% achieved remission according to the second definition. All 56% were considered to have a relapsing-remitting disease pattern, in contrast to the remaining 44% with a persistent disease pattern. More patients with persistent disease were treated with disease-modifying anti-rheumatic drugs (DMARDs) and had also received a larger number of different drugs. Outcome after 5 yr regarding disability, joint inflammation and joint damage was worse for patients with persistent disease. Neither ARA-defined remission nor disease pattern could be accurately predicted.</p><p><strong>Conclusions: </strong>Long-term ARA-defined remission was rare, constituting 7% of follow-up for the entire cohort. For those 20% achieving remission, this period represented 34% of their follow-up. A total of 56% had a relapsing-remitting disease pattern and 44% had a persistent disease pattern. This classification had prognostic implications with persistency being a bad prognostic sign.</p>","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1324-9"},"PeriodicalIF":0.0000,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1324","citationCount":"89","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rheumatology/37.12.1324","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 89

Abstract

Objective: To investigate the clinical course in early rheumatoid arthritis (RA) patients followed prospectively, to relate course to outcome after 5 yr, and to try to identify prognostic features.

Methods: A total of 183 patients with definite RA and a mean disease duration of 11 months were included. Of these, 75% were rheumatoid factor (RF) positive; 85% carried the shared epitope, 32% on both alleles. Most patients were assessed every 6 months. Disability was evaluated with the Health Assessment Questionnaire (HAQ) and radiographic findings according to Larsen. Remission was defined in two ways: with the American Rheumatism Association (ARA) criteria and as 'no arthritis at least at one follow-up visit'.

Results: Twenty per cent achieved ARA-defined remission periods of at least 6 months duration; 21 were spontaneous and 18 drug induced. Average length of remission was 20.5 months. The remission periods constituted 7% of follow-up for all patients. Another 36% achieved remission according to the second definition. All 56% were considered to have a relapsing-remitting disease pattern, in contrast to the remaining 44% with a persistent disease pattern. More patients with persistent disease were treated with disease-modifying anti-rheumatic drugs (DMARDs) and had also received a larger number of different drugs. Outcome after 5 yr regarding disability, joint inflammation and joint damage was worse for patients with persistent disease. Neither ARA-defined remission nor disease pattern could be accurately predicted.

Conclusions: Long-term ARA-defined remission was rare, constituting 7% of follow-up for the entire cohort. For those 20% achieving remission, this period represented 34% of their follow-up. A total of 56% had a relapsing-remitting disease pattern and 44% had a persistent disease pattern. This classification had prognostic implications with persistency being a bad prognostic sign.

早期类风湿关节炎患者的临床病程和缓解率:与5年后预后的关系
目的:探讨前瞻性随访的早期类风湿性关节炎(RA)患者的临床病程,将病程与5年后的预后联系起来,并试图确定预后特征。方法:183例确诊RA患者,平均病程11个月。其中75%为类风湿因子(RF)阳性;85%的人携带共享表位,32%的人携带两个等位基因。大多数患者每6个月进行一次评估。用健康评估问卷(HAQ)和放射学检查结果对残疾进行评估。缓解有两种定义:符合美国风湿病协会(ARA)的标准,以及“至少在一次随访中没有关节炎”。结果:20%达到ara定义的缓解期至少6个月;21例自发,18例药物诱导。平均缓解时间为20.5个月。缓解期占所有患者随访时间的7%。根据第二种定义,另有36%的患者获得了缓解。所有56%的患者被认为是复发缓解型疾病,而其余44%的患者则是持续性疾病。更多的持续性疾病患者接受了改善疾病的抗风湿药物(DMARDs)治疗,并且接受了更多不同的药物治疗。对于持续性疾病患者,5年后的残疾、关节炎症和关节损伤的结局更糟。ara定义的缓解和疾病模式都不能准确预测。结论:ara定义的长期缓解是罕见的,占整个队列随访的7%。对于那些达到缓解的20%,这段时间占他们随访的34%。总共56%的患者患有复发缓解型疾病,44%的患者患有持续性疾病。这种分类具有预后意义,持续性是一个不良的预后迹象。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信